Andrew Formica
Analyst · JP Morgan.
Ken, hi, it's Andrew here. The -- look, the first thing I'd say is, whether you reverse our decision, I think as the investment market has evolved and we've looked at the, really, the client demand and the landscape in Europe, it's clear that it's the -- it's become the sort of normal operating practice, or will become from the 1st of January. And you're right, it's from the 1st of January. That for European clients or MiFID-related business, they're taking that expense hard. In terms of quantifying the cost of -- it's not really something you would go do at the stage. It's fair to say that the price of research, as several on the phone would probably be able to attest, is changing quite dramatically at the moment, and also, as part of the budgeting process and the price discovery and the -- sort of the usage of research, and being more tailored in that research. So even if we were to look at historical costs, they are significantly higher than what we would anticipate and expect the going-forward rate would be, both equal to the price coming down as well as the utilization coming down. I think it will come in from 2018, and 2018 will be like a year of discovery, I guess, for the whole industry, in terms of how this model operates and where it's going to, and throughout that year we'll probably be in a better position. But as we see here today, we don't see it as that significant an impact, but to be able to quantify it wouldn't be fair, and I don't think there's a number we could put on that. I think there's -- so that's probably the best way to leave it for now, but as we work through 2018, we'll probably be in a better picture. Because it is quite a moving feat, and it does just relate to our European or MiFID-related business.